MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Boston Therapeutics, Inc. (BTHE) Reaches Agreement For Marketing SugarDown In The US 0 comments
    Feb 11, 2014 2:09 PM | about stocks: BTHE

    Today before the opening bell, Boston Therapeutics announced that it had signed a consulting agreement with Generosus Advisors, LLC and Fortified Management Group, LLC to market SugarDown® in the United States on a non-exclusive basis. The marketing of SugarDown will be done via the Help Now Networks, a healthcare marketing company, and its affiliates.

    Kenneth A. Tassey, Jr., President, Boston Therapeutics, said, "In our marketing agreement for SugarDown in the United States, we are working with a company that has a broad knowledge of the needs of those who fit our ideal customer profile. HNN has created an impressive database of loyal members. We are confident that HNN will effectively communicate the benefits of SugarDown to these individuals and efficiently distribute the product when orders are placed."

    Thomas Scipione of Help Now Networks, added, "We are very excited to introduce SugarDown to our two million members. Over the past several years we have marketed many products that are beneficial to our members to help them better manage their disease. We plan to rollout a marketing campaign for SugarDown in the next few weeks. Help Now Networks is in the business of lead generation through digital media and telemarketing services. For the past five years HNN's primary focus has been in healthcare of which diabetes has been our core campaign."

    As of now, Health Now Networks maintains a database of its affiliate of some 2 million members, of whom many fit SugarDown's target market. SugarDown is an over-the-counter, chewable tablet that, when taken prior to meals, is designed to reduce post-meal elevation in glucose. The food supplement will be test-marketed via trained outbound call center outreach and electronic media. Health Now Networks will be managing fulfillment of all customer orders and other distribution channels.

    For more information on Boston Therapeutics and SugarDown, visit: bostonti.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: BTHE
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.